Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Understand use case viability by analyzing how a project solves a real problem, the size of the target market, and potential adoption barriers.
20,468 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
AI-powered data centers are fueling a breakout in infrastructure plays. They offer a viable alternative to chip stock...
Truist’s head of originations is pushing a curiosity-driven, AI-enabled approach to mortgage lending as rates and dem...
Realtracs warns of a June 1 cutoff for the Zillow feed unless updated IDX rules are met. The move could remake listin...
Hostile shifts in homebuilder M&A are triggering a wave of talent departures and tighter loan terms. The ripple effec...
Cardano canceled its planned 2026 Summit in Singapore after a treasury voting process blocked funding, signaling the ...
Broadcom prepares to report earnings, with AI-powered momentum fueling expectations. Investors confront the question ...
A comprehensive IG review examines safety standards, platform tools, and regulatory reach as market conditions tilt t...
NVIDIA CEO Jensen Huang doubles down on AI’s role as a hiring accelerator, disputing calls for widespread job losses ...
From the brink to AI dominance, AMD’s decade-long rebound reshapes how investors view chipmakers. Here’s what the num...
Better Home & Finance and Coinbase unveil the first Fannie Mae-backed mortgage using bitcoin as collateral, signaling...
May payrolls rose by 172,000, with April revisions lifting the prior month. Unemployment stayed at 4.3% as the Fed we...